Investment Trusts

Worldwide Healthcare

WWH:LSE

Worldwide Healthcare

Actions
  • Price (GBX)353.05
  • Today's Change-2.45 / -0.69%
  • Shares traded104.97k
  • 1 Year change+4.76%
  • Beta0.5172
Data delayed at least 20 minutes, as of Feb 11 2026 11:27 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Total returns on £1000

1Y
Fund/benchmarkChange
PriceWorldwide Healthcare (Ordinary Share)+5.53%
NAVWorldwide Healthcare (Ordinary Share)-0.21%
Morningstar's BenchmarkMSCI World Health Care GR--

Key statistics

As of last trade Worldwide Healthcare (WWH:LSE) traded at 353.05, -11.08% below its 52-week high of 397.03, set on Nov 26, 2025.
52-week range
Today
256.54Apr 07 2025397.03Nov 26 2025
Short selling activity
Low
Med
High
Provided by S&P Global Market Intelligence
Shares outstanding383.33m
Market cap1.36bn GBP
Total assets1.55bn GBP
Total expense ratio--
High356.00
Low352.00
Previous close355.50
Average volume1.10m
YTD Change-5.98%
Beta0.5172
Diluted NAV (est)381.99
Diluted NAV (last pub)380.44
Premium/Discount-6.93%
Net Gearing+1.69%
Annual div (ADY)2.40
GBX
Annual div yield (ADY)0.68%
Div ex-dateNov 27 2025
Div pay-dateJan 09 2026
Data delayed at least 20 minutes, as of Feb 11 2026 11:27 GMT.
More ▼

Board of Directors

1/7

Doug McCutcheon, Chairman

2/7

Sven H. Borho

3/7

Dr Bandhana (Bina) Rawal

4/7

Tim Livett

5/7

Joanne Parfrey

6/7

Sian Hansen

7/7

William Hemmings

Contact

Registered Office:
One Wood Street
London
EC2V 7WS

Alternative Investment Fund Manager, Company Secretary and Administrator
Frostrow Capital LLP
25 Southampton Buildings
London
WC2A 1AL

T: 0203 008 4910
E: info@frostrow.com
W: www.frostrow.com
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.